DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Endroit courant :
>
> This Story


Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

Empowering patients is more transformational than you thought (or feared) Understanding a shifting paradigm in the care continuum

J. Michael Losh Cardinal Health appoints member to board of directors

Dr. Michael Rosol Navidea Biopharmaceuticals appoints chief medical officer

MDW aims to combat radiologist shortage with blockchain Connecting radiologists seeking volume to the facilities that need reading support

Dr. Hermann Requardt United Imaging Healthcare appoints senior scientific advisor

United Imaging Healthcare makes US debut at RSNA Bringing MR, CT, X-ray and PET/CT manufacturing to Houston

Dr. Jaewon Ryu Geisinger appoints interim president and CEO

Dr. Kent Thielen Mayo Clinic appoints CEO of its Florida operations; board of trustees names two new members

Medical charities do measurable good in the world A look at some organizations bringing goods and services where they are needed most

Mike Lobinsky EOS Imaging appoints new President North America

Stryker to acquire Invuity for $7.40 per share in cash

par Thomas Dworetzky , Contributing Reporter
Invuity, a leading medical technology maker of tools to boost visualization during surgery, has announced a deal in which it will go to Stryker for $7.40 per share in cash – valuing the firm at about $190 million.

“The combination of Stryker's established leadership in minimal access surgery paired with Invuity’s suite of enabling visualization and surgical devices should facilitate better patient outcomes and operating room efficiencies in women’s health, general surgery, electrophysiology and orthopedics,” Invuity’s Interim Chief Executive Officer Scott Flora said in a statement.

Story Continues Below Advertisement

Dunlee announces the relaunch of DA135 CT/e, DA165NP and Akron tubes

Dunlee announces the return of the DA135 CT/e, DA165NP, S532B and S532Q(known as the Akron tubes) CT Replacement tubes, making its full portfolio of CT tubes for GE and Siemens CT scanners available once again.Click to learn more



The deal terms will have a Stryker subsidiary make the tender offer for all outstanding Invuity common stock shares at the cash price, subject to the usual terms and closing conditions.

After the tender offer is successfully finished, using cash on hand, Stryker will merge with and into Invuity. After the deal, slated to close in Q4 2018, Invuity will be delisted from NASDAQ.

Invuity’s products in the single-use lighted instrumentation and hybrid energy markets offer “best-in-class illumination,” thanks to its patented Intelligent Photonics, making for safer surgery, noted Spencer S. Stiles, Stryker group president for Neurotechnology, Instruments and Spine. “I look forward to the work we will do together to advance Stryker’s mission of making healthcare better.”

In August, the company introduced the full commercial launch of PhotonGuide Adapt, its system, including a flexible illuminator and a family of compatible retractors, for surgical procedures performed vaginally including pelvic organ prolapse repairs and vaginal hysterectomies.

PhotonGuide Adapt lets surgeons seamlessly adjust the illumination along the length of the retractor to accommodate the surgical target. The pairing of the flexible illuminator with a range of compatible retractors optimizes visualization deep into the surgical cavity.

“The PhotonGuide Adapt launch marks a major milestone in our commitment to advancing surgical procedures in women’s health,” Scott Flora, President and CEO of Invuity, said in a statement. “We now have a comprehensive product portfolio designed to meet the clinical and economic needs of surgical gynecologists and their female patients.”

In other Stryker acquisition news, the firm announced August 30, that it had formed a definitive merger agreement to acquire all shares of common stock of K2M Group Holdings for $27.50 per share, making the value of that firm about $1.4 billion.

K2M is a key player in the $10 billion spinal market, with yearly sales near $300 million, and brings to Stryker's spine division a portfolio that will build up its offerings in the core spinal segment, including an attractive, minimally-invasive spine portfolio.

"This acquisition underscores our commitment to the spinal market, which is the largest segment of orthopedics with significant unmet needs," stated Kevin A. Lobo, chairman and chief executive officer, Stryker. "We believe K2M will significantly enhance our presence with surgeons, patients and employees in both the spine and related neurotechnology markets."

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Publicité
Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Annuaire
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Les travaux/Formation
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Certification Récentes
Voir les utilisateurs récemment certifiés
Evaluation Récentes
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service le forum de techniciens
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2018 DOTmed.com, Inc.
TOUS DROITS RÉSERVÉS